MSCI index

Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.

FAST NEWS: AIM Vaccine’s loss balloons

The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
6660.HK

Recent Articles

RELATED ARTICLES

  1. After a Beijing IPO last year, the loss-making biotech has also filed for a Hong Kong listing to better compete in the crowded market for HPV vaccines.
    Health Guard plans dual listing to fund HPV vaccine fight
  2. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
  3. Lopal Tech seeks cash after losses balloon with lithium price plunge
  4. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  5. Payment app Lianlian seeks IPO relief from cash crunch
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva